Laboratory Medicine and Quality Assurance

Table. 7.

Number (%) of participants in proficiency tests for antibody screening

Trial Specimen No. or participants (%) Negative (%) Positive (%) Intended response
1st BBG-19-01 316 (100) 1 (0.3)* 315 (99.7) Positive
BBG-19-02 316 (100) 1 (0.3)* 315 (99.7) Positive
BBG-19-03 316 (100) 316 (100) 0 Negative
2nd BBG-19-07 317 (100) 316 (99.7) 1 (0.3) Negative
BBG-19-08 317 (100) 0 317 (100) Positive
BBG-19-09 317 (100) 1 (0.3)* 316 (99.7) Positive

*Unacceptable responses for antibody screening,

Lab Med Qual Assur 2020;42:112~120 https://doi.org/10.15263/jlmqa.2020.42.3.112
© Lab Med Qual Assur